Interim CMO @ Dianthus Therapeutics (June 2021 - March 2024)
SVP, Clinical Development @ (June 2020 - April 2021)
SVP, Head of Clinical Development @ LogicBio Therapeutics (February 2019 - June 2020)
Vice President Clinical Development @ Bioverativ (July 2017 - February 2019)
Senior Translational Medicine Expert II @ (February 2015 - July 2017)
Vice President, Clinical Development @ Edimer Pharmaceuticals (January 2013 - February 2015)
Senior Director, Clinical Research @ Edimer Pharmaceuticals (January 2010 - January 2013)
Medical Director @ (January 2007 - January 2009)
Kenneth Huttner Education
Yale University
BS/MS/MD/PhD (Biology/Human Genetics)
Kenneth Huttner Skills
Biotechnology
Clinical Development
Clinical Research
Clinical Trials
Drug Development
Drug Discovery
FDA
GCP
Lifesciences
Medicine
Regulatory Affairs
Business Development
Leadership
Healthcare
Customer Service
Public Speaking
Kenneth Huttner Summary
Kenneth Huttner, based in Cambridge, MA, US, is currently a Interim CMO at Pretzel Tx. Kenneth Huttner brings experience from previous roles at KMHuttner LLC, Dianthus Therapeutics, Neurogene Inc. and LogicBio Therapeutics. Kenneth Huttner holds a BS/MS/MD/PhD in Biology/Human Genetics @ Yale University. With a robust skill set that includes Biotechnology, Clinical Development, Clinical Research, Clinical Trials, Drug Development and more. Kenneth Huttner has 1 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Kenneth Huttner?
Find contact details for 700 million professionals.